Skip to content
Reticular logo

Reticular

Reticular is a YC Fall 2024 (F24) company. Based in San Francisco, CA, USA. Team of 2.

  • AI-powered Drug Discovery
  • Generative AI
  • Biotech
  • Therapeutics

About Reticular

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Reticular builds interpretability tools for AI models used in drug discovery, targeting pharma and biotech companies. Its technology makes protein models such as AlphaFold steerable, letting researchers direct biological outputs with precision rather than running costly trial-and-error experiments. This replaces the manual, validation-heavy process of probing black-box models to find which inputs produce desired therapeutic effects.

Go-to-market

Reticular sells to pharma and early-stage biotech teams running computational drug discovery programs, and is currently expanding through direct pilots with those customers.

From the Y Combinator listing

How Reticular describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Interpretable AI for drug discovery

Reticular helps pharma companies discover drugs with AI models like AlphaFold by making them steerable, just like you can prompt LLMs. Today, limited validation data means companies spend millions on failed experiments trying to steer these models through trial and error. We’re piloting our AI interpretability technology with early-stage biotechs and scaling rapidly. Just a week after our pivot, we identified the first interpretable features ever found in protein models, allowing precise control over biological functions. Nithin and John met competing in Biology Olympiads before spending 4 years as roommates at MIT publishing ML/bio research in NeurIPS and Nature. We believe biological models encode far more information than anyone is currently using - our goal is to unlock this potential.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA
Team size
2
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works